Skip to main content
Top
Published in: BMC Cancer 1/2019

Open Access 01-12-2019 | Hysterectomy | Research article

Total hysterectomy versus uterine evacuation for preventing post-molar gestational trophoblastic neoplasia in patients who are at least 40 years old: a systematic review and meta-analysis

Authors: Peng Zhao, Yongchao Lu, Wei Huang, Baoqin Tong, Weiguo Lu

Published in: BMC Cancer | Issue 1/2019

Login to get access

Abstract

Background

The clinical value of total hysterectomy for patients with hydatidiform mole (HM) being at least 40 years old remains highly controversial. Since the practice of hysterectomy has been applied globally for decades, there is an urgent need to perform a systematic review to assess its risks and benefits.

Methods

Six electronic databases, including four English databases and one Chinese database, were searched from the inception of each database till October 6th 2017. Studies were included if they: 1) were human studies, 2) explicitly indicated exposure to hysterectomy, 3) explicitly indicated control to uterine evacuation, 4) explicitly indicated the participants were older patients with HM being at least 40 years in age, 5) compared the outcome of interest as the incidence of post-molar GTN. Two authors independently conducted the literature search, study selection, data extraction. Pooled odds ratios were analyzed using Review Manager 5.3.

Results

The overall pooled effect size of total hysterectomy had a significant advantage in preventing post-molar gestational trophoblastic neoplasia over uterine evacuation with an OR of 0.19 (95% CI, 0.08–0.48; P = 0.0004) and a low heterogeneity (I2 = 21%, P = 0.28). Subgroup analysis and sensitivity analysis also showed similar results.

Conclusions

Total hysterectomy, as compared to uterine evacuation, is a better therapeutic method for patients with HM being at least 40 years old unless fertility is still desired.
Appendix
Available only for authorised users
Literature
1.
go back to reference Eysbouts YK, et al. The added value of hysterectomy in the management of gestational trophoblastic neoplasia. Gynecol Oncol. 2017;145:536–42.CrossRef Eysbouts YK, et al. The added value of hysterectomy in the management of gestational trophoblastic neoplasia. Gynecol Oncol. 2017;145:536–42.CrossRef
2.
go back to reference Wang Q, et al. Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia. Cochrane Database Syst Rev. 2017;9:CD007289.PubMed Wang Q, et al. Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia. Cochrane Database Syst Rev. 2017;9:CD007289.PubMed
3.
go back to reference Hammond CB, Hertz R, Ross GT, Lipsett MB, Odell WD. Diagnostic problems of choriocarcinoma and related trophoblastic neoplasms. Obstet Gynecol. 1967;29:224–9.PubMed Hammond CB, Hertz R, Ross GT, Lipsett MB, Odell WD. Diagnostic problems of choriocarcinoma and related trophoblastic neoplasms. Obstet Gynecol. 1967;29:224–9.PubMed
4.
go back to reference Doll KM, Soper JT. The role of surgery in the management of gestational trophoblastic neoplasia. Obstet Gynecol Surv. 2013;68:533–42.CrossRef Doll KM, Soper JT. The role of surgery in the management of gestational trophoblastic neoplasia. Obstet Gynecol Surv. 2013;68:533–42.CrossRef
5.
go back to reference Stroup DF, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA. 2000;283:2008–12.CrossRef Stroup DF, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA. 2000;283:2008–12.CrossRef
6.
go back to reference Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603–5.CrossRef Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603–5.CrossRef
7.
go back to reference Niedhammer I, et al. Response to letter to the editor from Dr Rahman Shiri: The challenging topic of suicide across occupational groups. Scand J Work Environ Health. 2018;44:108–10. Niedhammer I, et al. Response to letter to the editor from Dr Rahman Shiri: The challenging topic of suicide across occupational groups. Scand J Work Environ Health. 2018;44:108–10.
8.
go back to reference Zhu Z, et al. Relationship of obstructive sleep Apnoea with diabetic retinopathy: a meta-analysis. Biomed Res Int. 2017;2017:4737064.PubMedPubMedCentral Zhu Z, et al. Relationship of obstructive sleep Apnoea with diabetic retinopathy: a meta-analysis. Biomed Res Int. 2017;2017:4737064.PubMedPubMedCentral
9.
go back to reference Schneck A. Examining publication bias-a simulation-based evaluation of statistical tests on publication bias. PeerJ. 2017;30:e4115.CrossRef Schneck A. Examining publication bias-a simulation-based evaluation of statistical tests on publication bias. PeerJ. 2017;30:e4115.CrossRef
10.
go back to reference Mavridis D, Salanti G. How to assess publication bias: funnel plot, trim-and-fill method and selection models. Evid Based Ment Health. 2014;17:30.CrossRef Mavridis D, Salanti G. How to assess publication bias: funnel plot, trim-and-fill method and selection models. Evid Based Ment Health. 2014;17:30.CrossRef
11.
go back to reference Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264–9 W64.CrossRef Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264–9 W64.CrossRef
12.
go back to reference Elias KM, Goldstein DP, Berkowitz RS. Complete hydatidiform mole in women older than age 50. J Reprod Med. 2010;55:208–12.PubMed Elias KM, Goldstein DP, Berkowitz RS. Complete hydatidiform mole in women older than age 50. J Reprod Med. 2010;55:208–12.PubMed
13.
go back to reference Elias KM, Shoni M, Bernstein M, Goldstein DP, Berkowitz RS. Complete hydatidiform mole in women aged 40 to 49 years. J Reprod Med. 2012;57:254–8.PubMed Elias KM, Shoni M, Bernstein M, Goldstein DP, Berkowitz RS. Complete hydatidiform mole in women aged 40 to 49 years. J Reprod Med. 2012;57:254–8.PubMed
14.
go back to reference You D, Hong S, Xin G. The prophylactic hysterectomy for patients with hydatidiform mole who were at least 40 years old. Xian Dai Fu Ke Xue Jin Zhan. 1996:141–2. You D, Hong S, Xin G. The prophylactic hysterectomy for patients with hydatidiform mole who were at least 40 years old. Xian Dai Fu Ke Xue Jin Zhan. 1996:141–2.
15.
go back to reference Zhao P, Chen Q, Lu W. Comparison of different therapeutic strategies for complete hydatidiform mole in women at least 40 years old: a retrospective cohort study. BMC Cancer. 2017;17(1):733.CrossRef Zhao P, Chen Q, Lu W. Comparison of different therapeutic strategies for complete hydatidiform mole in women at least 40 years old: a retrospective cohort study. BMC Cancer. 2017;17(1):733.CrossRef
16.
go back to reference Lertkhachonsuk R, Lertkhachonsuk AA. Outcomes of hysterectomy versus evacuation in elderly hydatidiform mole. Int J Gynecol Cancer. 2016;26(Supplement 3):539. Lertkhachonsuk R, Lertkhachonsuk AA. Outcomes of hysterectomy versus evacuation in elderly hydatidiform mole. Int J Gynecol Cancer. 2016;26(Supplement 3):539.
17.
go back to reference Giorgione V, et al. Role of surgery in the Management of Hydatidiform Mole in elderly patients: a single-center clinical experience. Int J Gynecol Cancer. 2017;27(3):550–3.CrossRef Giorgione V, et al. Role of surgery in the Management of Hydatidiform Mole in elderly patients: a single-center clinical experience. Int J Gynecol Cancer. 2017;27(3):550–3.CrossRef
18.
go back to reference Nakashima A, Miyoshi A, Miyatake T, Kazuhide O, Takeshi Y. Perimenopausal invasive hyadatidiform mole treated by total abdominal hysterectomy followed by chemotherapy. J Surg Case Rep. 2016. Nakashima A, Miyoshi A, Miyatake T, Kazuhide O, Takeshi Y. Perimenopausal invasive hyadatidiform mole treated by total abdominal hysterectomy followed by chemotherapy. J Surg Case Rep. 2016.
19.
go back to reference Pisal N, North C, Tidy J, Hancock B. Role of hysterectomy in management of gestational trophoblastic disease. Gynecol Oncol. 2002;87:190–2.CrossRef Pisal N, North C, Tidy J, Hancock B. Role of hysterectomy in management of gestational trophoblastic disease. Gynecol Oncol. 2002;87:190–2.CrossRef
20.
go back to reference Suprasert P, Siriaree S, Manopunya M. Outcomes of metastatic gestational trophoblastic neoplasia: fourteen year experience from a northern Thailand tertiary care center. Asian Pac J Cancer Prev. 2016;17:1357–62.CrossRef Suprasert P, Siriaree S, Manopunya M. Outcomes of metastatic gestational trophoblastic neoplasia: fourteen year experience from a northern Thailand tertiary care center. Asian Pac J Cancer Prev. 2016;17:1357–62.CrossRef
21.
go back to reference Fang J, et al. Role of adjuvant hysterectomy in management of high-risk gestational trophoblastic neoplasia. Int J Gynecol Cancer. 2012;22:509–14.CrossRef Fang J, et al. Role of adjuvant hysterectomy in management of high-risk gestational trophoblastic neoplasia. Int J Gynecol Cancer. 2012;22:509–14.CrossRef
22.
go back to reference Aminimoghaddam S, Maghsoudnia A. Unusual presentation of invasive mole: a case report. J Reprod Infertil. 2017;18:205–9.PubMedPubMedCentral Aminimoghaddam S, Maghsoudnia A. Unusual presentation of invasive mole: a case report. J Reprod Infertil. 2017;18:205–9.PubMedPubMedCentral
23.
go back to reference Hammond CB, Weed JJ, Currie JL. The role of operation in the current therapy of gestational trophoblastic disease. Am J Obstet Gynecol. 1980;136:844–58.CrossRef Hammond CB, Weed JJ, Currie JL. The role of operation in the current therapy of gestational trophoblastic disease. Am J Obstet Gynecol. 1980;136:844–58.CrossRef
24.
go back to reference Altieri A, Franceschi S, Ferlay J, Smith J, La Vecchia C. Epidemiology and aetiology of gestational trophoblastic diseases. Lancet Oncol. 2003;4:670–8.CrossRef Altieri A, Franceschi S, Ferlay J, Smith J, La Vecchia C. Epidemiology and aetiology of gestational trophoblastic diseases. Lancet Oncol. 2003;4:670–8.CrossRef
25.
go back to reference Maestá I, et al. Prognostic factors associated with time to hCG remission in patients with low-risk postmolar gestational trophoblastic neoplasia. Gynecol Oncol. 2013;130:312–6.CrossRef Maestá I, et al. Prognostic factors associated with time to hCG remission in patients with low-risk postmolar gestational trophoblastic neoplasia. Gynecol Oncol. 2013;130:312–6.CrossRef
26.
go back to reference Tsuji K, Yagi S, Nakano R. Increased risk of malignant transformation of hydatidiform moles in older gravidas: a cytogenetic study. Obstet Gynecol. 1981;58:351–5.PubMed Tsuji K, Yagi S, Nakano R. Increased risk of malignant transformation of hydatidiform moles in older gravidas: a cytogenetic study. Obstet Gynecol. 1981;58:351–5.PubMed
Metadata
Title
Total hysterectomy versus uterine evacuation for preventing post-molar gestational trophoblastic neoplasia in patients who are at least 40 years old: a systematic review and meta-analysis
Authors
Peng Zhao
Yongchao Lu
Wei Huang
Baoqin Tong
Weiguo Lu
Publication date
01-12-2019
Publisher
BioMed Central
Keyword
Hysterectomy
Published in
BMC Cancer / Issue 1/2019
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-018-5168-x

Other articles of this Issue 1/2019

BMC Cancer 1/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine